Sugimoto M - Search Results

1

Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.

Nishida A, Hidaka K, Kanda T, Imaeda H, Shioya M, Inatomi O, Bamba S, Kitoh K, Sugimoto M, Andoh A. Nishida A, et al. Among authors: sugimoto m. Inflamm Bowel Dis. 2016 Feb;22(2):303-14. doi: 10.1097/MIB.0000000000000654. Inflamm Bowel Dis. 2016. PMID: 26752465

2

Interleukin(IL)-36α and IL-36γ Induce Proinflammatory Mediators from Human Colonic Subepithelial Myofibroblasts.

Kanda T, Nishida A, Takahashi K, Hidaka K, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A. Kanda T, et al. Among authors: sugimoto m. Front Med (Lausanne). 2015 Sep 22;2:69. doi: 10.3389/fmed.2015.00069. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26442271 Free PMC article.

3

Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis.

Ichikawa H, Sugimoto M, Sugimoto K, Andoh A, Furuta T. Ichikawa H, et al. Among authors: sugimoto m, sugimoto k. J Gastroenterol Hepatol. 2016 Apr;31(4):716-26. doi: 10.1111/jgh.13233. J Gastroenterol Hepatol. 2016. PMID: 26580676

4

Asada A, Nishida A, Shioya M, Imaeda H, Inatomi O, Bamba S, Kito K, Sugimoto M, Andoh A. Asada A, et al. Among authors: sugimoto m. J Gastroenterol. 2016 Jan;51(1):22-9. doi: 10.1007/s00535-015-1142-4. Epub 2015 Nov 21. J Gastroenterol. 2016. PMID: 26590936

5

[Cases of Three Patients with Gastric Cancer and Metastasis to the Skeletal Muscle].

Sugitani Y, Inatomi O, Tanabe R, Kanda T, Sonoda A, Hasegawa H, Osaki R, Imaeda H, Ban H, Nishida A, Shioya M, Bamba S, Sugimoto M, Tsujikawa T, Andoh A. Sugitani Y, et al. Among authors: sugimoto m. Gan To Kagaku Ryoho. 2015 Nov;42(11):1419-21. Gan To Kagaku Ryoho. 2015. PMID: 26602403 Japanese.

6

Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.

Sugimoto M, Uotani T, Ichikawa H, Andoh A, Furuta T. Sugimoto M, et al. Digestion. 2016;93(1):24-31. doi: 10.1159/000441741. Epub 2016 Jan 14. Digestion. 2016. PMID: 26789391 Review.

7

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.

Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A. Takahashi K, et al. Among authors: sugimoto m. Digestion. 2016;93(1):59-65. doi: 10.1159/000441768. Epub 2016 Jan 14. Digestion. 2016. PMID: 26789999

8

Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis.

Morita Y, Bamba S, Takahashi K, Imaeda H, Nishida A, Inatomi O, Sasaki M, Tsujikawa T, Sugimoto M, Andoh A. Morita Y, et al. Among authors: sugimoto m. Scand J Gastroenterol. 2016 Aug;51(8):934-41. doi: 10.3109/00365521.2016.1144781. Epub 2016 Feb 18. Scand J Gastroenterol. 2016. PMID: 26888161

9

Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease.

Morita Y, Imaeda H, Nishida A, Inatomi O, Bamba S, Sasaki M, Tsujikawa T, Sugimoto M, Andoh A. Morita Y, et al. Among authors: sugimoto m. J Gastroenterol Hepatol. 2016 Nov;31(11):1831-1836. doi: 10.1111/jgh.13400. J Gastroenterol Hepatol. 2016. PMID: 27043158

10

Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.

Sugimoto M, Sahara S, Ichikawa H, Kagami T, Ban H, Otsuka T, Andoh A, Furuta T. Sugimoto M, et al. Helicobacter. 2017 Feb;22(1). doi: 10.1111/hel.12319. Epub 2016 May 23. Helicobacter. 2017. PMID: 27213463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,382 results

Search Page

Filters